Catalyst

Slingshot members are tracking this event:

AMGN presents results for Repatha (evolocumab) Cardiovascular Outcomes Trial (FOURIER) at the American College of Cardiology 66th Annual Scientific Session

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AMGN Community voting in process
MDCO Community voting in process
SNY Community voting in process
REGN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 17, 2017
Related Keywords Repatha, Evolocumab, American College Of Cardiology, Acc '17, Fourier, Outcomes Trial